SIGLEC1 and neoplasm: Since presence of SCS CD169+ macrophages in lymph nodes of cancer patients are associated with a better prognosis, it is important to understand their precise involvement in local anti-tumor immune reactions, to understand why they disappear from LNM and what impact this has on local lymph node immune reactivity.